Últimas noticias sobre Ovid Therapeutics (NASDAQ:OVID) Bolsa

Ovid Therapeutics

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

Ovid Therapeutics Inc

<ul>
<li>TSLA</li>
<li>NVDA</li>
<li>LUNR</li>
<li>AAPL</li>
<li>MSTR</li>
<li>AMD</li>
<li>CVNA</li>
<li>QQQ</li>
<li>RKLB</li>
<li>GOOG</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

Trading Ideas

AAPL

CVNA

GOOG

LUNR

MSTR

NVDA

RKLB

TSLA

Top 10 Trending Stocks On WallStreetBets As Of January 2, 2025 (Via Swaggy Stocks)

Shares of Kopin Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOPN#NASDAQ">KOPN</a>) were <a href="https://www.benzinga.com/quote/KOPN">climbing in early trading on Thursday</a>.
The provider of advanced microdisplays for military applications is poised to benefit from the continued growth of defense budgets across the U.S. and NATO countries, according to Canaccord Genuity.
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/619bb1b28a6ef800019b5d2d/george-gianarikas">Analyst George Gianarikas</a> initiated coverage of Kopin with a Buy rating and a price target of $2.
The Kopin Thesis: While the defense market contributes around 80% of revenues, the company is exploring new growth avenues in the civilian market, Gianarikas said in the initiation note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Kopin could benefit from the rising interest in augmented reality/virtual reality (AR/VR) technologies, which offers "promising prospects" in consumer electronics and medical applications, he added.
"CEO Michael Murray (started September 2022) continues to improve operations, resulting in a potential turn to profitability in 2025," the analyst wrote. "We further see optionality as the company could look to expand either through targeted acquisitions or as an acquisition target itself," he further stated.
Price Action: Shares of Kopin had risen by 4.41% to $1.42 at the time of publication on Thursday.
Read More: <a href="https://www.benzinga.com/24/12/42535789/quicklogic-is-poised-to-benefit-from-cold-war-20-weaponization-of-outer-space-says-bullish-analyst">QuickLogic Analyst Sees &#8216;Cold War 2.0&#8217; As Growth Catalyst</a>
Image: Shutterstock

Analyst Color

Long Ideas

Initiation

Analyst Ratings

KOPN

Kopin Explores New Growth Avenues Beyond Defense, Poised To Turn Profitable In 2025

News

Stock Split

IDAI

Trust Stamp To Implement 1-For-15 Reverse Stock Split Effective January 6, 2025

Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) has outperformed the market over the past 10 years by 9.12% on an annualized basis producing an average annual return of 20.37%. Currently, Boston Scientific has a market capitalization of $131.90 billion. 
Buying $1000 In BSX: If an investor had bought $1000 of BSX stock 10 years ago, it would be worth $6,537.96 today based on a price of $89.57 for BSX at the time of writing.
<h3>Boston Scientific's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1735836310_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today

Jefferies analyst David Katz maintains Sunstone Hotel Invts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHO#NYSE">SHO</a>) with a Hold and raises the price target from $10 to $12.

Price Target

Jefferies Maintains Hold on Sunstone Hotel Invts, Raises Price Target to $12

BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) shares are<a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener"> trading higher on Thursday.</a>
The company has announced a rebranding of its division, previously known as &#8216;BlackBerry IoT,&#8217; renaming it &#8216;QNX&#8217; and relaunching the brand to strengthen its presence in the automotive and <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/ac42763883/blackberry-unveils-strategic-relaunch-of-qnx-brand-to-reinforce-leadership-in-automotive-and-gene" rel="noreferrer noopener">embedded industries.</a>
The move, which stems from feedback from customers, partners, and employees, marks a milestone in QNX&#8217;s history, emphasizing its role in powering next-generation Software-Defined Vehicles and mission-critical systems.
Acquired by BlackBerry in 2010, QNX has become a prominent player in real-time operating systems. In the last fiscal year, QNX launched the QNX SDP 8.0, a scalable foundation for next-generation automotive and IoT systems, alongside QNX Sound, an audio innovation platform for SDVs, and QNX Everywhere, an initiative designed to spur a more open development environment for QNX technologies.
John J. Giamatteo, CEO of BlackBerry, highlighted that this rebranding is part of the company&#8217;s strategy to increase visibility and leadership in these industries, with a focus on growth and innovation.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42763048/powering-up-charging-tesla-to-deploy-first-v4-superchargers-in-china-by-2025" rel="noreferrer noopener">Tesla To Deploy First V4 Superchargers In China By 2025: Report</a>
QNX technology is already integrated into over 255 million vehicles worldwide, as well as critical systems in healthcare, industrial controls, robotics, and more.
&#8220;BlackBerry is at an inflection point and QNX is well positioned for the next 10 years as the demand for advanced hybrid cloud/edge computing capabilities becomes crucial for driving a software-defined future. The investments we have made over the last three years have set us on a well-defined path to capitalize on these trends,&#8221; said Mattias Eriksson, President, QNX.
To accompany the rebranding, BlackBerry unveiled a refreshed logo, website, and visual identity, which will be showcased at CES 2025 in Las Vegas.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, BB stock has gained over 14% in the past year. Investors can gain exposure to the stock via&nbsp;SPDR S&amp;P Kensho Future Security ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FITE#NYSE">FITE</a>).
Price Action: BB shares are trading higher by 4.23% to $3.94 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/25/01/42757919/joe-biden-addresses-new-orleans-attack-says-law-enforcement-probing-links-with-cybertruck-explosion-outside-trump-hotel-in-las-vegas" target="_blank" rel="noreferrer noopener">Joe Biden Addresses New Orleans Attack Says Law Enforcement Probing Links With Cybertruck Explosion Outside Trump Hotel In Las Vegas</a></li>
</ul>

Equities

Markets

Movers

Tech

General

FITE

BlackBerry Rebrands IoT Division As QNX - What's Driving The Change?

Jefferies analyst David Katz maintains Xenia Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XHR#NYSE">XHR</a>) with a Buy and raises the price target from $18 to $20.

Jefferies Maintains Buy on Xenia Hotels & Resorts, Raises Price Target to $20

Jefferies analyst David Katz maintains Park Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PK#NYSE">PK</a>) with a Buy and lowers the price target from $23 to $22.

Jefferies Maintains Buy on Park Hotels & Resorts, Lowers Price Target to $22

Carmell Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTCX#NASDAQ">CTCX</a>) disclosed that it has entered into a definitive purchase agreement with PMGC Holdings Inc. (formerly Elevai Labs Inc.) and its subsidiary, Elevai Skincare Inc., for purchase consideration, which includes around $1.1 million in <a href="https://www.benzinga.com/pressreleases/25/01/g42762528/carmell-announces-execution-of-definitive-agreement-to-acquire-elevai-skincare-a-leader-in-physici" target="_blank" rel="noreferrer noopener">Carmell stock at the closing of the acquisition</a>.
Additionally, Carmell will pay around $57,000 in cash for the sale of specified inventory existing as of the closing.
Furthermore, the acquisition includes contingent earnout considerations. This comprises 5% of net sales from Elevai&#8217;s existing products, which will be paid annually over the next five years.
A one-time milestone payment of $500,000 will be made if Elevai&#8217;s hair and scalp products generate $500,000 in net revenue within 24 months of the closing.
Lastly, Carmell will assume Elevai&#8217;s contractual liabilities and trade payables at the time of closing.
Carmell expects to acquire several assets from Elevai as part of the acquisition.
These assets include a product portfolio with trailing twelve-month revenue of approximately $2.5 million, as well as the commercial and product development team.
Additionally, Carmell will acquire finished and work-in-process inventory valued at approximately $1.0 million, along with accounts receivable of about $30,000.
Rajiv Shukla, chairman of Carmell said, &#8220;This acquisition will integrate one of the newest advances in stem cell derived exosome technology into the Carmell platform, further cementing our status as the home of the best bio-aesthetic skincare science, Built by Biology just as Nature intended.&#8221;
As of Sept. 30, 2024, the company had cash and cash equivalents <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318716575&amp;type=PDF&amp;symbol=CTCX&amp;cdn=364b0da5c720a5cb08623287e5aeba2e&amp;companyName=Carmell+Corporation&amp;formType=10-Q&amp;formDescription=General+form+for+quarterly+reports+under+Section+13+or+15%28d%29&amp;dateFiled=2024-11-14" target="_blank" rel="noreferrer noopener">of </a>$25,297.
Last week, the company entered into a securities purchase <a target="_blank" href="https://www.benzinga.com/news/financing/24/12/42673289/why-biotechnology-company-carmell-shares-are-seeing-blue-skies-tuesday" rel="noreferrer noopener">agreement&nbsp;with new and existing investors</a>.
The agreement involves the issuance and sale of 8,065,210 shares of common stock and an equal number of five-year warrants, both priced at $0.23 per share, in a private placement.
Price Action: CTCX shares are up 215.8% at $0.88 premarket at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42764308" target="_blank" rel="noreferrer noopener">D.O.G.E. Zooms 48% Higher Ahead Of Elon Musk-Led Agency Launching In January: &#8216;Ready For The Next Leg Up,&#8217; Millionaire Trader Vows</a></li>
</ul>
Photo: Shutterstock

Health Care

Small Cap

CTCX

Why Biotechnology Company Carmell Shares Are Rocketing On Thursday

An arctic air blast across the U.S. is driving up heating demand and creating volatile <a href="https://www.benzinga.com/markets/commodities">conditions in energy markets</a>.
What Happened: Natural gas futures bounced back Thursday morning, with February contracts climbing by over 2% to $3.71 per million British units.
According to the National Weather Center (NWC), "Periods of locally heavy coastal rains and higher elevation snow continue for much of the northwestern U.S."
See Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42764583/mortgage-rates-soar-to-697-applications-crash-jobless-claims-fall-thursdays-econ-data">Mortgage Rates Soar To 6.97%, Applications Crash, Jobless Claims Fall: Thursday&#8217;s Economic Data</a>
The next two days will see a deluge of rain and snow over the Northwest. The heaviest moisture will target the northern California coast and Oregon today. The NWC highlighted an isolated threat of flash flooding in these areas.
"Accumulating snow is possible over the highest elevations of the Cascades, Sierra and Northern Rockies," the NWC added, noting that snow showers will continue in the Northern and Central Rockies, while rain and snow showers expand across the Northwest on Friday.
The Great Lakes region is bracing for heavy snowfall, with isolated areas expecting accumulations of up to one foot. Snowfall of six to 12 inches is also forecast for parts of the Central Appalachians by Friday.
Why It Matters: Winter weather is driving much of the action, and liquefied natural gas (LNG) exports continue to fuel demand as Natural Gas Intel reported.
Natural gas-related stocks posted notable gains by mid-morning Thursday, reflecting optimism about rising demand and cold-driven volatility in the market.
U.S. natural gas prices — as tracked by the United States Natural Gas Fund LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNG#NYSE">UNG</a>) — have risen by 15% over the past month.
Pipeline giant ONEOK Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKE#NYSE">OKE</a>) soared 1.57%, trading at $102.28, while Kinder Morgan Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMI#NYSE">KMI</a>), a major natural gas transporter, advanced 2% to $27.94.
Shares of NGL Energy Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NGL#NYSE">NGL</a>) rose 1.2% to $5.05. It was buoyed by expectations of increased activity in the natural gas infrastructure sector.
What&#8217;s Next: Traders are anxiously awaiting Friday&#8217;s U.S. Energy Information Administration storage report.
Withdrawal estimates for the week ended Dec. 27 range from 77 to 159 billion cubic feet, with an average expectation of 127 Bcf.
If realized, the 127 Bcf draw would erase much of the 166 Bcf surplus left after last week's 93 Bcf withdrawal. For comparison, last year's pull for the same period was just 35 Bcf, while the five-year average is 104 Bcf.
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/tech/25/01/42757901/elon-musk-fireworks-or-explosive-device-caused-fatal-cybertruck-incident-at-las-vegas-trump-hotel-vehicle-was-rented">Elon Musk: Fireworks Or Explosive Device Caused Fatal Cybertruck Incident At Las Vegas Trump Hotel</a></li>
</ul>
Image: Shutterstock

Large Cap

Mid Cap

Sector ETFs

Specialty ETFs

Commodities

Econ #s

Economics

ETFs

Natural Gas Prices Surge As Arctic Blast Freezes US: 3 Stocks On The Move

Rentals from peer-to-peer car-sharing company Turo were used in the New Year's Day attacks in both Las Vegas <a href="https://www.benzinga.com/media/25/01/42756901/10-killed-dozens-hurt-in-new-orleans-terrorist-attack-truck-drives-into-bourbon-street-new-years-crowd">and New Orleans.</a>
Here's a look at how the company is involved and what comes next.
What Happened: Attacks that used vehicles in New Orleans and<a href="https://www.benzinga.com/general/entertainment/25/01/42757028/tesla-cybertruck-ignites-outside-trump-international-hotel-in-las-vegas"> Las Vegas on Wednesday</a> left at least 16 people dead and dozens more injured.
Peer-to-peer car-sharing company Turo, which is often referred to as the Airbnb of vehicles, issued a <a href="https://turo.com/blog/news/an-update-on-todays-incidents-in-new-orleans-and-las-vegas/">statement </a>on the use of Turo rentals in the attacks. 
"It is with a heavy heart that we confirm that this morning's horrific attack in New Orleans and this afternoon's Tesla Cybertruck explosion in Las Vegas both involved vehicles rented on Turo. Our thoughts and prayers are with the victims and their families," Turo said in a statement.
Turo said it is working with law enforcement to help the investigations. The company said it does not believe either renter had a "criminal background" that would have flagged them as a security threat. Turo also said there is no evidence at this time that the two attacks are connected.
"We are devastated by these horrible incidents, and remain dedicated to helping the authorities however we can."
In the attack on Bourbon Street in New Orleans, a Ford F-150 Lightning truck was used. In Las Vegas, a Tesla Cybertruck exploded outside the Trump Hotel. Both vehicles are electric pickup trucks.
The owner of the F-150 Lightning recognized his vehicle from news footage of the attack and the license plate, as <a href="https://www.nytimes.com/2025/01/01/us/turo-new-orleans-attack-vegas-explosion.html">reported </a>by the New York Times. The truck's owner said he rents out five vehicles on Turo for a secondary income source but plans to stop this practice after the attack.
Read Also: <a href="https://www.benzinga.com/24/12/42642606/elon-musk-wants-to-raise-a-tesla-fleet-expert-estimates-vehicle-owners-can-make-40kyear-but-remains-doubtful">Tesla Analyst Estimates Vehicle Owners Can Make $40,000 A Year By Renting EVs To Robotaxi Fleet That Elon Musk Likened To A Combination Of Airbnb And Uber, But Will It Take Off?</a>
About Turo: The car-sharing company started in 2009 with venture capital backing, seeking to use a model similar to Airbnb to connect consumers with vehicles that were not being used by their owners.
Unlike traditional car rental companies, users on Turo can often find vehicles located in more convenient spots close to home or work instead of having to go to a car rental retail location. The rates and fees can also be cheaper when using Turo, although this can depend on the prices set by vehicle owners themselves on the app.
A November filing, shared by the New York Times, said around 3.5 million people have used Turo to book a vehicle and around 150,000 people have listed their vehicles for rent on the platform.
In order to use the Turo platform, users have to create an account, have a valid driver's license and payment method. Users also have to be 18 years of age in the United States, which is younger than most car rental companies that set the minimum at 20 or 21. Turo also often checks credit history, auto insurance scores and criminal background history and is able to decline rentals and ban users.
Turo users do not need to have their own car insurance to rent a vehicle, as they can select from three protection plans.
In September, Turo <a href="https://turo.com/blog/news/uber-and-turo-partner-to-share-vehicles-on-uber-rent/">announced </a>a partnership with Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>). The partnership gives Uber customers the ability to rent vehicles from Turo directly through the Uber app.
Turo is available in the United States, Canada, United Kingdom, France and Australia, according to the company's website.
What's Next: Turo filed paperwork to go public in 2022. It did not go public in 2024 and is one of many companies that mount a 2025 IPO.
Turo is backed by dozens of investors through multiple funding rounds. IAC Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAC#NASDAQ">IAC</a>) is among the largest investors in the company, with a $250 million investment made in <a href="https://turo.com/blog/news/iac-invests-250-million-in-turo/">2019 </a>at a valuation of $1 billion, helping to make the company the biggest shareholder.
The car-sharing company had revenue of $880 million in 2023, up 18% year-over-year. The company's 2023 profit was $14.7 million, down from $154.7 million in 2022, as <a href="https://www.businessinsider.com/what-is-turo-car-rental-app-las-vegas-new-orleans-2025-1">reported </a>by Business Insider.
Insurance bought by the renters on Turo for the vehicles used in the Wednesday attacks and the insurance policies owned by the vehicle owners could become a key topic for Turo in connection with potential liability claims.
The issue of approval of vehicle renters and Turo&#8217;s background check process are also likely to be in the spotlight. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/global/25/01/42757919/joe-biden-addresses-new-orleans-attack-says-law-enforcement-probing-links-with-cybertruck-explosion-outside-trump-hotel-in-las-vegas">Joe Biden Addresses New Orleans Attack Says Law Enforcement Probing Links With Cybertruck Explosion Outside Trump Hotel In Las Vegas</a></li>
</ul>
Photo via Shutterstock.

Media

UBER

Turo Rentals Used In New Orleans, Las Vegas Attacks: 'We Are Devastated By These Horrible Incidents'

MicroAlgo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) shares are trading higher Thursday after the company announced the development of a hybrid <a href="https://www.benzinga.com/pressreleases/25/01/n42763951/microalgo-inc-develops-hybrid-classical-quantum-algorithms-to-optimize-multi-query-problems">classical-quantum algorithm.</a>
What To Know: The algorithm addresses Multi-Query Optimization (MQO) problems, which are classified as NP-hard and have applications in fields like database query optimization, machine learning and network routing. The innovation combines the stability of classical computing with the efficiency of quantum computing.
Key aspects of the algorithm include efficient qubit utilization with a reported 99% efficiency, the integration of classical error correction mechanisms to reduce computational error rates, scalability to handle problems of different sizes and compatibility with existing gate-based quantum computers.
MicroAlgo claims its algorithm can effectively handle smaller-scale MQO problems while improving qubit utilization and reducing computational error rates. Experimental evaluations reportedly confirm its performance under current quantum computing limitations.
MLGO Price Action: MicroAlgo shares were up 7.7% at $4.05 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga pro.</a>
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="545" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02105044/Screenshot-2025-01-02-at-10.50.02-1024x545.png" alt="" class="wp-image-715496" style="width:421px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02105044/Screenshot-2025-01-02-at-10.50.02-1024x545.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02105044/Screenshot-2025-01-02-at-10.50.02-300x160.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02105044/Screenshot-2025-01-02-at-10.50.02-768x409.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02105044/Screenshot-2025-01-02-at-10.50.02.png 1499w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/01/42767647/chinese-stocks-drop-as-manufacturing-growth-slows-and-geopolitical-tensions-hit">Chinese Stocks Drop As Manufacturing Growth Slows And Geopolitical Tensions Hit</a></li>
</ul>
Photo by solarseven on Shutterstock.

MLGO

MicroAlgo Shares Are On The Rise today: What You Need To Know

Jefferies analyst David Katz maintains Choice Hotels Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHH#NYSE">CHH</a>) with a Hold and raises the price target from $150 to $152.

Jefferies Maintains Hold on Choice Hotels Intl, Raises Price Target to $152

Jefferies analyst David Katz maintains Wyndham Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WH#NYSE">WH</a>) with a Buy and raises the price target from $107 to $120.

Jefferies Maintains Buy on Wyndham Hotels & Resorts, Raises Price Target to $120

Rolex SA, the Swiss luxury watchmaker, has raised prices on several of its models following an upswing in gold prices in 2024, <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-01-02/rolex-kicks-off-2025-by-hiking-watch-prices-after-gold-soars?srnd=phx-industries&amp;sref=TBDibEcD" rel="noreferrer noopener">Bloomberg</a> reported.
According to the report, the price of the yellow gold Day-Date and yellow gold GMT-Master II has increased by almost 8% to 44,200 euros and 44,600 euros, respectively.
The price hikes follow gold&#8217;s remarkable 27% gain in 2024, reflecting its role as a safe-haven asset that remains prominent amid global economic uncertainties and geopolitical tensions.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/12/42666501/starbucks-faces-major-strike-on-christmas-eve-300-locations-affected-as-5000-workers-walk-out" rel="noreferrer noopener">Starbucks Faces Major Strike On Christmas Eve: 300+ Locations Affected As 5,000 Workers Walk Out</a>
While Rolex traditionally adjusts prices at the beginning of the year, this year&#8217;s changes surpass the 4% increases seen for some of its models in the beginning of 2024, Bloomberg noted.
According to a report, the gold prices are expected to continue their upward trajectory and reach $2,795 per troy ounce by the end of 2025, a <a target="_blank" href="https://www.benzinga.com/markets/commodities/25/01/42759408/gold-prices-to-climb-7-in-2025-amid-trumps-return-to-white-house-and-geopolitical-tensions-momentum-is-taking-back-over" rel="noreferrer noopener">7% increase from current levels</a>.
Central banks are likely to drive demand as they diversify reserves in the midst of geopolitical uncertainties.
Key drivers of the expected increase include central banks&#8217; diversification away from the U.S. dollar following sanctions on Russia, anticipated interest rate cuts by the U.S. Federal Reserve, and rising concerns about U.S. <a target="_blank" href="https://www.benzinga.com/24/12/42594797/trump-wants-to-get-rid-of-the-debt-ceiling-30-year-treasury-bonds-fall-to-2024-lows-stocks-cut-gains" rel="noreferrer noopener">government debt</a> under President-elect&nbsp;Donald Trump.
As per&nbsp;<a target="_blank" href="https://pro.benzinga.com/" rel="noreferrer noopener">Benzinga Pro</a>, gold ETFs have increased in the past year as of Tuesday, 31st Dec.&nbsp;SPDR&nbsp;Gold Shares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>) was up by 26.85%,&nbsp;iShares Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IAU#NYSE">IAU</a>) rose by 26.85%, and&nbsp;abrdn Physical Gold Shares ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGOL#NYSE">SGOL</a>) was up by 26.90%.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42729529/social-media-stocks-react-as-trump-targets-censorship-and-delays-tiktok-ban" target="_blank" rel="noreferrer noopener">Trump Administration to Challenge Social Media Censorship, Setting Stage for Conflict with EU Regulations</a></li>
</ul>
Photo by panlertb via Shutterstock

GLDM

OUNZ

SGOL

Gold Price Surge Pushes Rolex to Raise Prices for Iconic Watches

Looking into the current session, NVR Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVR#NYSE">NVR</a>) shares are trading at $8143.15, after a 0.44% decrease. Over the past month, the stock fell by 9.07%, but over the past year, it actually increased by 17.37%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1735835409_0.png" alt="Past Year Chart" />

<h3>Evaluating NVR P/E in Comparison to Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of 12.64 in the Household Durables industry, NVR Inc. has a higher P/E ratio of 16.74. Shareholders might be inclined to think that NVR Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1735835409_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

A Look Into NVR Inc's Price Over Earnings

American Tower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMT#NYSE">AMT</a>) has outperformed the market over the past 20 years by 3.71% on an annualized basis producing an average annual return of 12.05%. Currently, American Tower has a market capitalization of $85.06 billion. 
Buying $1000 In AMT: If an investor had bought $1000 of AMT stock 20 years ago, it would be worth $9,692.23 today based on a price of $182.02 for AMT at the time of writing.
<h3>American Tower's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1735835408_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) shares are trading higher Thursday following <a href="https://www.benzinga.com/25/01/42761126/why-microstrategy-shares-are-trading-higher-by-over-5-here-are-20-stocks-moving-premarket">an increase in Bitcoin</a> (CRYPTO: BTC/USD)'s price to $96,578.38, according to<a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2"> Benzinga Pro.</a>
What To Know: Despite gaining 342% year-to-date in 2024, MicroStrategy has experienced a 23% decline over the past month. The stock closed at $289.62 on Wednesday, trading below its eight, 20 and 50-day simple moving averages, signaling a bearish short-term trend. However, it remains above its 200-day moving average of $195.03, indicating long-term bullish potential.
Analysts have set a consensus price target of $449.50 for MicroStrategy, with a high of $690 from BTIG on Dec. 11, 2023, and a low of $140 from Jefferies on Nov. 10, 2022. Recent ratings from Bernstein, TD Cowen and Barclays in late 2024 suggest an average price target of $546.67, implying a potential upside of 77.91%.
The company's stock performance is directly tied to Bitcoin's fluctuations due to its heavy investment in the cryptocurrency. While Bitcoin&#8217;s rise has previously led to gains for MicroStrategy, it also exposes the company to volatility.
Galaxy Research projects that Bitcoin could exceed $150,000 in early 2025, with a potential peak of $185,000 by the year's end, driven by increased institutional and corporate adoption.
MSTR Price Action: MicroStrategy shares were up 4.33% at $302.67 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga pro.</a>
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="521" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02102503/Screenshot-2025-01-02-at-10.24.35-1024x521.png" alt="" class="wp-image-715449" style="width:531px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02102503/Screenshot-2025-01-02-at-10.24.35-1024x521.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02102503/Screenshot-2025-01-02-at-10.24.35-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02102503/Screenshot-2025-01-02-at-10.24.35-768x391.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/02102503/Screenshot-2025-01-02-at-10.24.35.png 1527w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/01/42766729/why-vs-media-holdings-vsme-stock-is-skyrocketing">Why VS Media Holdings (VSME) Stock Is Skyrocketing</a></li>
</ul>
Image via Shutterstock.

MicroStrategy Shares Are Up Today: What's Going On?

Jefferies analyst David Katz maintains Hyatt Hotels (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/H#NYSE">H</a>) with a Hold and raises the price target from $150 to $176.

Jefferies Maintains Hold on Hyatt Hotels, Raises Price Target to $176

Jefferies analyst David Katz maintains Hilton Worldwide Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>) with a Hold and raises the price target from $237 to $277.

Jefferies Maintains Hold on Hilton Worldwide Holdings, Raises Price Target to $277

Oppenheimer analyst Francois Brisebois maintained a Hold rating on Ovid Therapeutics (OVID – Research Report) today. The company's shares closed ye...

Oppenheimer Sticks to Their Hold Rating for Ovid Therapeutics (OVID)

H.C. Wainwright analyst Ram Selvaraju has reiterated their bullish stance on OVID stock, giving a Buy rating on September 27. Ram Selvaraju has giv...

Buy Rating Affirmed for Ovid Therapeutics on Promising Safety Profile and Robust Pipeline Progress

Thomas Shrader, an analyst from BTIG, maintained the Buy rating on Ovid Therapeutics (OVID – Research Report). The associated price target remains ...

Ovid Therapeutics: Promising Safety Profile and Growth Potential Underpin Buy Rating

Reports Q3 revenue $173,000, consensus $90k. "The biopharmaceutical industry is entering an exciting new era of neurotherapeutics, and we are poise...

Ovid Therapeutics reports Q3 EPS (20c), consensus (20c)

Ovid Therapeutics GAAP EPS of -$0.20 misses by $0.01, revenue of $0.17M beats by $0.1M

Ritu Baral, an analyst from TD Cowen, has initiated a new Buy rating on Ovid Therapeutics (OVID). Ritu Baral has given his Buy rating due to a comb...

Ovid Therapeutics: Strategic Developments and Financial Stability Lead to Buy Rating

Wedbush analyst Laura Chico maintained a Buy rating on Ovid Therapeutics (OVID – Research Report) today and set a price target of $4.00. The compan...

Ovid Therapeutics (OVID) Gets a Buy from Wedbush

Ovid Therapeutics (OVID) will present four posters that support the Company's OV329 and OV350 pipeline programs for the treatment of conditions cau...

Ovid to present posters on pipeline program for neuronal hyperexcitability

In a report released yesterday, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Ovid Therapeutics (OVID – Research Report), with a pr...

Ovid Therapeutics' KCC2 Activators Show Promise for Excitability Disorders: Analyst Recommends Buy with $3 Price Target

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Beam Therapeutics (BEAM – Research Report) and Ovid ...

Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM) and Ovid Therapeutics (OVID)

BEAM

OVID

Legal

Press Releases

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID

Ligand Reports Second Quarter 2024 Financial Results

Management

Ovid Therapeutics Appoints Dr. Amanda Banks, Experienced Biotech Leader & Physician as Chief Development Officer

Earnings

Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results

Ovid Therapeutics to Present at Upcoming September Investor Conferences

Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future Growth

Ovid Therapeutics Presents Pre-Clinical Study Results Demonstrating OV329 Does Not Accumulate in Animal Eyes in Contrast with Vigabatrin

Ovid Therapeutics to Host Investor Event

Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results

Ovid Therapeutics to Present Multiple Posters Supporting Its Pipeline Programs Targeting Neuronal Hyperexcitability at the American Epilepsy Society 2024 Annual Meeting

Comments

Ovid Therapeutics

Noticias

Últimas noticias sobre Ovid Therapeutics (NASDAQ:OVID) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL